Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris

May 23, 2013

Kona Surround SoundĀ® Technology Utilizes Externally-Delivered Ultrasound to Treat Drug-Resistant Hypertension
More »

Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team

May 15, 2013

Dr. Apelian will be responsible for the clinical development of Achillion's portfolio of compounds to treat HCV. In addition, Achillion added Kevin Kucharski, formerly head of clinical operations at Pharmasset, as Senior VP of Clinical Operations.
More »

CelatorĀ® Pharmaceuticals Raises $32.5 Million Completing A $39.3 Million Private Placement Financing

April 30, 2013

Celator raised $39.3 million to support the late-stage clinical development of the Company's lead investigational product, CPX-351 (cytarabine:daunorubicin) Liposome Injection, which is being studied in a Phase 3 clinical study.
More »